نتائج البحث 121-130 من 2290 لعملية البحث عن anti-TNF drugs
Scottsdale/Phoenix, Ariz. The purpose of this study is to test drug enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive ...
... treatment for patients with solid tumors or non-Hodgkin lymphomas. Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy ...
The purpose of this study is to evaluate the effect of immunotherapy drugs (ipilimumab and nivolumab) in treating patients with glioblastoma that has come back ...
Gender-affirming hormone therapy (adult). Mayo Clinic; 2022. Nippoldt TB (expert opinion). Mayo Clinic. Feb. 7, 2024. ذات صلة. اضطراب الهُوِية الجنسية ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
The primary purpose of Part 2 (Tumor Group Expansion Cohorts) of this study is to evaluate anti ... therapy for their underlying malignancy. ... drugs are safe for ...
The purpose of this study is to test drug enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC).
Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by ...
Finally, this study examines the effect of therapy intensification in patients who have RMS cancer with DNA mutations to see if their outcomes can be improved.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.